There is insufficient evidence to recommend bremelanotide for hypoactive sexual desire disorder
Document Type
Article
Publication Date
8-23-2021
Publication Title
Clinical Research in Practice: The Journal of Team Hippocrates
Abstract
An informed consent discussion for a patient with Hypoactive Sexual Desire Disorder.
Volume
7
Issue
1
First Page
eP2862
Recommended Citation
Yaekle S, Ali H, Baker C. Informed Consent: There is insufficient evidence to recommend bremelanotide for hypoactive sexual desire disorder. Clin. Res. Prac. Aug 23 2021;7(1):eP2862. doi: 10.22237/crp/1622161200
DOI
10.22237/crp/1622161200
COinS